Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Alternatives for Reducing Chorea in HD (ARC-HD)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Auspex Pharmaceuticals, Inc. )
ClinicalTrials.gov Identifier:
NCT01897896
First received: June 14, 2013
Last updated: December 1, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2017
  Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)